BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
BHVN
Delisted
BHVN was delisted on the 3rd of October, 2022.
328 hedge funds and large institutions have $8.76B invested in Biohaven Pharmaceutical Holding Company Ltd. in 2022 Q2 according to their latest regulatory filings, with 109 funds opening new positions, 98 increasing their positions, 98 reducing their positions, and 80 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
8% more funds holding
Funds holding: 305 → 328 (+23)
0% more repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 98
Holders
328
Holding in Top 10
30
Calls
$86.5M
Puts
$47.5M
Top Buyers
| 1 | +$415M | |
| 2 | +$284M | |
| 3 | +$283M | |
| 4 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$208M |
| 5 |
SFM
Soros Fund Management
New York
|
+$183M |
Top Sellers
| 1 | -$583M | |
| 2 | -$238M | |
| 3 | -$209M | |
| 4 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$202M |
| 5 |
Capital International Investors
Los Angeles,
California
|
-$169M |